Harish Rana v. Union of India: the first concrete grant of passive euthanasia

The facts in brief

In 2013, Harish Rana — then nineteen — fell from a building in Delhi and sustained catastrophic brain injury. He never recovered consciousness. For thirteen years he remained in a permanent vegetative state (PVS), fully dependent on artificial nutrition through a clinically assisted nutrition and hydration (CANH) regime and on continuous medical interventions, with no clinical prospect of recovering awareness. His parents and family cared for him at home through that period and bore the medical and emotional weight that the choice entailed.

By early 2026, the family approached the Supreme Court by writ petition seeking permission to withdraw the life-sustaining treatment that was keeping him biologically alive. The petition was framed under the Common Cause v. Union of India (2018) 5 SCC 1 framework — the Constitution Bench decision that laid down detailed guidelines for Advance Medical Directives and the withdrawal of futile treatment, but which had not been concretely applied by the Supreme Court itself to authorise a withdrawal in any subsequent case.

After hearing the matter, examining the reports of independent medical boards and considering the family's circumstances, a two-judge bench of Justice J.B. Pardiwala and Justice K.V. Viswanathan allowed the withdrawal on 11 March 2026. Justice Pardiwala wrote the lead opinion; Justice Viswanathan delivered a concurring opinion that engaged the procedural-safeguards architecture in detail. Pursuant to the order, Harish Rana was shifted from his residence to palliative care at AIIMS. He passed away on 24 March 2026. The Court subsequently lauded the family for organ donation.

The constitutional question

The petition placed two questions before the Court. The first was substantive: does Article 21 — the right to live with dignity — encompass the right to refuse or withdraw life-sustaining treatment in a PVS patient through a surrogate decision-maker exercising "best interests" judgment? The Constitution Bench in Common Cause had answered this in 2018 in principle, recognising the constitutional permissibility of passive euthanasia subject to Advance Medical Directives or surrogate-based safeguards. The question that Common Cause had not concretely resolved was whether the Court itself, in an individual writ, would authorise withdrawal.

The second question was definitional but doctrinally decisive: is CANH "medical treatment" or "basic care"? In Indian medico-legal practice the distinction had been left unclear after Aruna Shanbaug v. Union of India (2011) 4 SCC 454, which had refused to allow withdrawal of nasogastric feeding from a patient in a PVS. If CANH is treatment, it falls within the Common Cause withdrawal framework; if it is basic care, withdrawal is impermissible even where continuation is futile. The Court's answer would govern whether the Common Cause architecture had real operational scope or remained a doctrinal placeholder.

A third subsidiary question concerned the criminal law: does withdrawing CANH from a PVS patient expose the treating clinicians or family to liability under section 309 IPC (attempted suicide) or section 306 IPC (abetment of suicide)? Section 309 has been substantially softened by section 115 of the Mental Healthcare Act 2017, which presumes severe mental stress in any attempt; but the abetment dimension under section 306 had been left open in earlier writings.

What the Court held

CANH is medical treatment, not basic care

The central doctrinal contribution of the judgment is the re-classification of clinically assisted nutrition and hydration as medical treatment. The Court reasoned that CANH is not the equivalent of spoon-feeding or domestic care: it requires clinical insertion, ongoing clinical supervision, infection-control protocols, and continuous adjustment to physiological response. Each element marks the regime as a medical intervention. The conceptual line between treatment and nursing care is functional — whether the regime requires clinical decision-making to be initiated, maintained or terminated. CANH does, on each axis.

Clinically Assisted Nutrition and Hydration cannot be classified as primary care and is a medical treatment for all intents and purposes.

This re-classification aligns the Indian framework with the trajectory of the United Kingdom Airedale NHS Trust v. Bland (1993) line and the United States Cruzan v. Director, Missouri Department of Health (1990) line, both of which treat artificial nutrition as treatment capable of being withdrawn where continuation is no longer in the patient's interests. The judgment expressly notes this comparative convergence without subordinating Indian doctrine to it.

The "best interests" standard re-articulated

The Court anchored its analysis in the "best interests" standard articulated in Common Cause and Aruna Shanbaug. The standard had previously been read by some as asking whether death is in the patient's interests — a framing that imports unease about active causation. The Court rejected that reading.

The best-interests test does not ask if it is in the patient's interest to die; it asks if it is in their interest to continue life-sustaining treatment that offers no realistic hope of recovery.

The framing dissolves the perceived tension between Article 21 and the criminal law. Where continued treatment is futile — where no realistic prospect of recovery exists and the patient's clinical course is one of indefinite biological maintenance without consciousness — discontinuation is not the active causation of death but the withdrawal of an intervention that no longer serves the patient. The legal effect of continuing such treatment is itself a constitutional concern: the patient's dignity, the family's autonomy, and the integrity of medical practice are all imposed upon.

Sections 309 and 306 IPC do not extend to therapeutic withdrawal

The Court held that withdrawing futile medical treatment from a patient in a PVS does not amount to an attempt to suicide under section 309 IPC, nor to abetment of suicide under section 306 IPC. Section 309 presupposes a subject capable of intent to end his or her own life; a PVS patient has no such capacity, and the regime of artificial nutrition is not the patient's own act. Section 306 requires instigation, aid, or conspiracy directed at the patient's suicidal act; therapeutic withdrawal under the Common Cause framework is none of those. The criminal law cannot punish the legitimate exercise of constitutional rights to dignified end-of-life care.

This reasoning closes a longstanding apprehension among treating clinicians, who had feared section 306 liability for honouring family or surrogate decisions to discontinue treatment. The doctrinal closure is significant: it removes a chilling effect that had quietly impeded the operation of Common Cause in clinical practice.

First concrete application of the Common Cause framework

The judgment is foundational because it is the first occasion on which the Supreme Court itself has applied the Common Cause (2018) guidelines to authorise a withdrawal. Earlier writings under the framework had remained at the level of principle. By treating the procedural safeguards — independent medical board assessment, family consultation, palliative-care transition — as operative rather than aspirational, the Court has converted the Common Cause architecture into a working pathway. High Courts and Medical Boards now have a Supreme Court precedent to follow rather than a Constitution Bench framework to interpret in the abstract.

The doctrinal architecture

The judgment performs three doctrinal moves simultaneously.

First, it brings Indian end-of-life law into substantive alignment with the international jurisprudence that treats artificial nutrition as treatment. This is not mere comparativism — it resolves the open question that Aruna Shanbaug had left unresolved when it refused withdrawal of nasogastric feeding from Aruna Shanbaug herself. The Aruna Shanbaug refusal had been framed partly on a treatment-versus-basic-care line that the Court had not analytically defended; Harish Rana now supplies the defence and inverts the answer.

Second, it operationalises the Common Cause (2018) framework by demonstrating that the Supreme Court itself will apply the safeguards to authorise concrete withdrawal. This shifts the burden in subsequent Article 226 writs: families seeking withdrawal will now invoke Harish Rana as direct authority, not Common Cause as a guidelines document.

Third, it re-articulates the Article 21 dignity jurisprudence in the end-of-life register. Dignity, on this reading, is not only a right not to be subjected to indignity by the State — it is a right to have the State, the courts and the medical profession recognise the limits of medically maintained biological existence. The judgment sits alongside K.S. Puttaswamy in extending Article 21 beyond negative liberty into substantive autonomy over the conditions in which life is sustained or allowed to end.

What the judgment did not decide

The judgment did not authorise active euthanasia — the deliberate administration of a substance to cause death. The constitutional permissibility of active euthanasia remains an open question on which Common Cause and Aruna Shanbaug are settled in the negative. Harish Rana operates entirely within the passive-euthanasia framework: withdrawal of futile treatment, not affirmative termination of life.

The judgment did not address the position of patients with severe but non-PVS clinical conditions — for example, patients in minimally conscious states, advanced dementia, or terminal illness with preserved awareness. Each of these categories carries different considerations and will require separate analysis when test cases arise.

It did not address the operationalisation of Advance Medical Directives — the living-will registration architecture that Common Cause had laid down — beyond noting their continued availability. The procedural simplifications that Common Cause underwent in the 2023 modification application were not revisited.

It did not address insurance, succession, or pension consequences of treatment withdrawal. These questions sit downstream of the constitutional permissibility holding and will need to be worked through in regulatory and statutory frameworks over time.

After the judgment

The judgment is foundational for end-of-life law in India. Hospitals and palliative-care facilities will need to revise their CANH protocols in light of the re-classification, and Hospital Ethics Committees will need to align internal procedures with the Common Cause safeguards now that those safeguards are operative. Medical boards will be asked to perform PVS assessments more frequently and with greater procedural care. High Courts handling Article 226 writs for withdrawal of life-sustaining treatment will now apply Harish Rana directly rather than navigating the Common Cause framework as an unmediated guidelines document.

Legislative attention is likely. A private member's bill on the Aruna Shanbaug / Common Cause terrain has been intermittently before Parliament; the concrete application in Harish Rana sharpens the case for statutory codification of the framework, including detailed safeguards for surrogate decision-making and for institutional review.

Advance-directive registration — the living-will pathway — is expected to gain traction, both as a personal-autonomy choice and as a procedural simplification for families who wish to avoid the writ pathway in the event of catastrophic incapacity. The judgment will be a major reference in clinical-ethics teaching and in the curricula of nursing and medical schools, where the boundary between treatment and care has long been taught with the older orthodoxy.

International comparative discussion has already increased. The British Bland line, the American Cruzan line, and the more recent European Court of Human Rights jurisprudence on end-of-life autonomy will be argued alongside Harish Rana in academic and practitioner writing, with Indian doctrine now occupying a recognisable position in the comparative landscape.

Related on Valkya

• Common Cause v. Union of India: Advance Medical Directives and passive euthanasia
• Aruna Shanbaug v. Union of India: passive euthanasia recognised in principle
• K.S. Puttaswamy v. Union of India: the nine-judge privacy declaration
• Prabhu Kumar v. State of Himachal Pradesh: the RPwD Act 40% floor, not a ceiling

Sources

1. LiveLaw — Harish Rana v. Union of India case page (2026 LiveLaw SC 229): https://www.livelaw.in/sc-judgments/2026-livelaw-sc-229-harish-rana-v-union-of-india-526043
2. Supreme Court Observer — "In a first, Supreme Court gives green signal for passive euthanasia": https://www.scobserver.in/journal/in-a-first-supreme-court-gives-green-signal-for-passive-euthanasia/
3. Bar and Bench — "Passive euthanasia: What are best interests of a patient in vegetative state — Supreme Court explains": https://www.barandbench.com/news/passive-euthanasia-what-are-best-interests-of-a-patient-in-vegetative-state-supreme-court-explains
4. Common Cause v. Union of India, (2018) 5 SCC 1 — Constitution Bench guidelines on Advance Medical Directives and passive euthanasia
5. Aruna Ramchandra Shanbaug v. Union of India, (2011) 4 SCC 454 — two-judge bench articulation of the "best interests" framework